OrbiMed’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History

OrbiMed’s Portfolio KNTE Stock Details KNTE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-8,009,729	Closed	-$21.3M	–	127
2024 Q1	$21.3M	Hold	8,009,729	–	–	0.39%	61
2023 Q4	$19M	Hold	8,009,729	–	–	0.38%	63
2023 Q3	$11.2M	Hold	8,009,729	–	–	0.24%	80
2023 Q2	$24.3M	Buy	8,009,729 +2,866,100	+56%	+$11M	0.44%	62
2023 Q1	$32.1M	Buy	5,143,629 +1,100,000	+27%	+$6.7M	0.63%	52
2022 Q4	$24.7M	Hold	4,043,629	–	–	0.47%	62
2022 Q3	$48.3K	Hold	4,043,629	–	–	0.9%	42
2022 Q2	$51K	Hold	4,043,629	–	–	0.92%	36
2022 Q1	$45.5M	Buy	4,043,629 +195,700	+5%	+$2.15M	0.74%	42
2021 Q4	$68.2M	Hold	3,847,929	–	–	0.88%	40
2021 Q3	$88.6M	Hold	3,847,929	–	–	0.97%	29
2021 Q2	$89.6M	Hold	3,847,929	–	–	0.91%	35
2021 Q1	$120M	Hold	3,847,929	–	–	1.12%	27
2020 Q4	$153M	Buy	+3,847,929	New	+$154M	1.34%	19

OrbiMed's KNTE Position: Q2 2024 in Review

OrbiMed sold out of Kinnate Biopharma Inc. Common Stock (KNTE) in Q2 2024, closing a stake of 8,009,729 shares — an estimated $21.3M sold.

OrbiMed first reported a position in KNTE in Q4 2020 and held it in 14 quarters. The position peaked at $153M in Q4 2020. 0 funds tracked by Wall St. Rank hold KNTE as of Q2 2024.

OrbiMed reported no remaining Kinnate Biopharma Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
OrbiMed sold 8,009,729 Kinnate Biopharma Inc. Common Stock shares in Q2 2024, an estimated $21.3M.
OrbiMed first reported a position in Kinnate Biopharma Inc. Common Stock in Q4 2020 and held it in 14 quarters.
OrbiMed's Kinnate Biopharma Inc. Common Stock position peaked at $153M in Q4 2020.
0 funds tracked by Wall St. Rank held Kinnate Biopharma Inc. Common Stock as of Q2 2024.

Based on OrbiMed's 13F filing for Q2 2024, filed 14 Aug 2024.